Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03716505 · ClinicalTrials.gov registry record · NA

Non-invasive Vagus Nerve Stimulation for the Prevention of Migraines

A NA study of Migraine Disorders, sponsored by ElectroCore.

Completed
Registry status
NA
Development phase
231
Enrollment target
20
Study locations

NCT03716505 is a NA study of Migraine Disorders that has completed, run by ElectroCore. The registered enrollment target is 231 participants, below the 304-participant average among 21 other Migraine Disorders trials with a reported enrollment target (24% lower). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03716505, a NA study of Migraine Disorders, has completed, sponsored by ElectroCore.

COMPLETED
Registry status
NA
Development phase
231 participants
Enrollment target
20
Study locations

Study Summary

The purpose of the study is to investigate if the use of gammaCore Sapphire™ device reduces the number of migraines preventatively.

Conditions Studied

Migraine Disorders

Interventions

  • DEVICE gammaCore Sapphire active
  • DEVICE gammaCore Sapphire Sham

Study Locations (20)

California

  • The Research Center of Southern California - Carlsbad
  • Stanford University Medical Center Hoover Pavilion - Palo Alto
  • UCSF Headache Center - San Francisco
  • California Medical Clinic for Headache - Santa Monica

Connecticut

  • New England Institute for Neurology and Headache - Stamford
  • Hartford HealthCare Headache Center - West Hartford

Illinois

  • Diamond Headache Clinic - Chicago
  • NorthShore Ambulatory Care Center - Glenview

Louisiana

  • Crescent City Headache and Neurology Center - Chalmette
  • Ochsner North Shore Medical Center - Covington

Missouri

  • StudyMetrix, LLC - City of Saint Peters
  • Clinvest Research - Springfield

Arizona

  • Mayo Clinic - Scottsdale

Colorado

  • Summit Headache and Neurologic Institute, PC - Englewood

Florida

  • University of Miami, Miller School of Medicine - Miami

Trial Details

FieldValue
Enrollment Target 231 participants
Start Date 2018-11-02
Est. Completion 2020-09-09
Phase NA

Sponsor

ElectroCore

6 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03716505

The ClinicalTrials.gov registry entry for NCT03716505 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 231 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 21 other Migraine Disorders trials with a reported enrollment target (24% lower). The listed sponsor is ElectroCore, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Migraine Disorders appearing as the primary indexed condition, and to 2 interventions - of which gammaCore Sapphire active is the first listed.

NCT03716505 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Connecticut, Illinois.

Frequently Asked Questions

What is clinical trial NCT03716505 about?

NCT03716505 is a clinical study titled "Non-invasive Vagus Nerve Stimulation for the Prevention of Migraines". The purpose of the study is to investigate if the use of gammaCore Sapphire™ device reduces the number of migraines preventatively.

What is the current status of trial NCT03716505?

This trial is currently completed. It is a NA study. The enrollment target is 231 participants. The study started on 2018-11-02. Estimated completion is 2020-09-09.

What conditions does trial NCT03716505 study?

This clinical trial studies the following conditions: Migraine Disorders.

What interventions are being tested in trial NCT03716505?

The interventions under investigation include: gammaCore Sapphire active (DEVICE), gammaCore Sapphire Sham (DEVICE).

Who is sponsoring clinical trial NCT03716505?

This trial is sponsored by ElectroCore, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03716505 being conducted?

This trial has 20 study locations across Arizona, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Migraine Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Migraine Disorders

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.